Critical Care Medicine
KZE has prepared a broad array of medical communication products in support of drugs developed for emergency response (e.g., cyanide poisoning), and critically ill patients (e.g., renal insufficiency and associated iron deficiency anemia, hepatic encephalopathy, pulmonary arterial hypertension, and sepsis). As part of critical care medicine, we have provided medical writing in support of an enzyme replacement therapy for a rare, inherited metabolic disease impacting bone development in infants and children.
Medical Writing Products
Peer reviewed clinical trial-based manuscripts
Medical Information letters
Patient Information materials
IND, NDA and BLA CTD components
Five-year publication planning and implementation for novel cyanide antidote
Bibliography: Sample Publications and Abstracts
C Charyton, MV Bernardo, T Koch, et al. Intravenous Ferric Carboxymaltose Versus Standard Medical Care in the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease: A Randomized, Active-Controlled, Multi-Center Study Nephrology Dialysis Transplantation, doi: 10.1093/ndt/gfs528, 2012.
CF Barish, T Koch, A Butcher, et al. Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials. Anemia, 2012: Article ID 172104, 9 pages, 2012.
P-F Laterre, SM Opal, E Abraham, SP et al. A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia. Critical Care 2009, 13:R36 2009.
AH Hall, R Dart, G Bogdan. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Annals Emer Med 49(6): 806-13, 2007.
FJ Baud. Cyanide: Critical issues in diagnosis and treatment. Human Exp Toxicol 26(3): 191-204, 2007.